Cerus reported $52.87M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Atrion ATRI:US 32.46M 922K
Cerulean Pharma CERU:US $ 8.4M 1.14M
Cerus CERS:US $ 52.87M 4.18M
Cytori Therapeutics CYTX:US $ 3.93M 13K
Haemonetics HAE:US $ 245.8M 21.68M
Meridian Bioscience VIVO:US $ 75.09M 7.03M
Nuvasive NUVA:US $ 278.83M 51.73M
Orasure Technologies OSUR:US $ 83.68M 10.75M
Quidel QDEL:US $ 381.6M 121.46M
Sientra SIEN:US 37.49M 1.12M
Staar Surgical STAA:US $ 51.09M 531K
Terumo 4543:JP Y 158316M 8069M
Utah Medical Products UTMD:US 7.47M 398K